GI Alliance - Texas Digestive Disease Consultants - Cedar Park — Cedar Park, Texas

GI Alliance - Texas Digestive Disease Consultants - Cedar Park is a clinical research site located in Cedar Park, Texas, United States 78613.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

GI Alliance - Texas Digestive Disease Consultants - Cedar Park has participated in 1 clinical trials.

Therapeutic areas: Clostridioides Difficile Infection.

Sponsors: Summit Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cedar Park

Browse all research sites in Texas · View every site in Cedar Park

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GI Alliance - Texas Digestive Disease Consultants - Cedar Park?

GI Alliance - Texas Digestive Disease Consultants - Cedar Park has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GI Alliance - Texas Digestive Disease Consultants - Cedar Park conducted?

GI Alliance - Texas Digestive Disease Consultants - Cedar Park has 1 clinical trials on record. Their work covers Clostridioides Difficile Infection.

Is GI Alliance - Texas Digestive Disease Consultants - Cedar Park accredited by Crixeo Clinical Trials?

GI Alliance - Texas Digestive Disease Consultants - Cedar Park has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GI Alliance - Texas Digestive Disease Consultants - Cedar Park?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.